Table 2.
Sham | OVX | |
---|---|---|
BW (g) | ||
4 week | 258 ± 11 | 283 ± 9Δ |
8 week | 275 ± 15 | 321 ± 10**,## |
Serum Ca (mg/dL) | ||
4 week | 10.05 ± 0.61 | 10.72 ± 0.28 |
8 week | 10.65 ± 0.58 | 9.05 ± 0.49*,# |
Urine Ca/Cre (mg/mg) | ||
4 week | 0.036 ± 0.002 | 0.048 ± 0.005 |
8 week | 0.042 ± 0.005 | 0.089 ± 0.008**,## |
Serum intact PTH (pg/mL) | ||
4 week | 106 ± 6.9 | 125 ± 7.2Δ |
8 week | 96 ± 6.9 | 137 ± 10.3* |
Serum FGF-23 (pg/mL) | ||
4 week | 368 ± 11.8 | 258.8 ± 6.4Δ |
8 week | 408 ± 15.2 | 175.1 ± 10.5**,# |
Serum TRACP-5b (U/L) | ||
4 week | 2.47 ± 0.16 | 2.94 ± 0.09Δ |
8 week | 2.69 ± 0.13 | 3.14 ± 0.11* |
Values are expressed as mean ± SEM, n = 10 in each group.
P < 0.05, versus Sham (4 week);
P < 0.05, versus Sham (8 week);
P < 0.001, versus Sham (8 week);
P < 0.05, versus OVX (4 week);
P < 0.01, versus OVX (4 week).
BW, body weight; Ca, calcium; Cre, creatinine; PTH, parathyroid hormone; FGF-23, fibroblast growth factor-23; TRACP-5b, tartrate resistant acid phosphatase-5b.